NRx Pharmaceuticals, Inc. (NRXP) Tops Q2 EPS by 1c,
Get Alerts NRXP Hot Sheet
Join SI Premium – FREE
NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) reported Q2 EPS of ($0.12), $0.01 better than the analyst estimate of ($0.13).
For earnings history and earnings-related data on NRx Pharmaceuticals, Inc. (NRXP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Paychex (PAYX) Tops Q1 EPS by 2c
- Top Wealth Group expects net profit to double in fiscal 2026
- Cintas Corp. (CTAS) Tops Q1 EPS by 1c, Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share